BioSpace News Archive

New findings to be presented at The North American Menopause Society (NAMS) 2020 Virtual Annual Meeting

ANGLE plc, a world-leading liquid biopsy company, announces that, under the Remuneration Policy approved by the shareholders at the Annual General Meeting on 30 October 2018, the Remuneration Committee has approved the grant under the Long-Term Incentive Plan of options over a maximum of 3,000,000 ordinary shares of £0.10, dependent on certain performance conditions, to the Company’s executive directors.

PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider announced the launch of pci | bridge, an innovative digital platform that will give customers immediate visibility into their clinical and commercial supply chain, and provide instantaneous data and insights to inform decision-making.

ROME Therapeutics, a biotechnology company harnessing the power of the repeatome in drug development, announced that it has been named by Fierce Biotech as one of 2020’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.

Stemedica Cell Technologies, Inc. has received U.S. FDA Investigational New Drug approval for “A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients with Moderate to Severe Lung Injury due to COVID-19.”

Carmine Therapeutics announced that it has been named by FierceBiotech as one of 2020’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.

A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results

Aurinia Pharmaceuticals Inc. announced that the last patient study visit has occurred in the Phase 2/3 AUDREY™ clinical study evaluating voclosporin ophthalmic solution for the potential treatment of dry eye syndrome.

Centogene N.V. announced that that the Company has been awarded ISO/IEC 27001:2017 certification following an extensive audit of its Information Security Management System.

Avivagen Inc. is pleased to announce that it has received a new purchase order for OxC-beta Livestock from Industrias Melder in Mexico through Avivagen’s Mexican consultant Meyenberg International Group.